Distinct Mechanisms of Receptor and Nonreceptor Tyrosine Kinase Activation by Reactive Oxygen Species in Vascular Smooth Muscle Cells: Role of Metalloprotease and Protein Kinase C-δ

REFERENCES

• Abe, J., and B. C. Berk. 1999. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J. Biol. Chem. 274: 21003–21010.
   PubMedGoogle Scholar
• Abe, J., and B. C. Berk. 1998. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc. Med. 8: 59–64.
   PubMed Web of Science ®Google Scholar
• Andreev, J., M. L. Galisteo, O. Kranenburg, S. K. Logan, E. S. Chiu, M. Okigaki, L. A. Cary, W. H. Moolenaar, and J. Schlessinger. 2001. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276: 20130–20135.
   PubMedGoogle Scholar
• Asakura, M., M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura, T. Yoshinaka, H. Ohmoto, K. Node, K. Yoshino, H. Ishiguro, H. Asanuma, S. Sanada, Y. Matsumura, H. Takeda, S. Beppu, M. Tada, M. Hori, and S. Higashiyama. 2002. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 8: 35–40.
   PubMed Web of Science ®Google Scholar
• Brown, C., K. Meise, G. Plowman, R. Coffey, and P. Dempsey. 1998. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. J. Biol. Chem. 273: 17258–17268.
   PubMedGoogle Scholar
• Carpenter, G. 1999. Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J. Cell Biol. 146: 697–702.
   PubMed Web of Science ®Google Scholar
• Chen, K., J. A. Vita, B. C. Berk, and J. F. Keaney. 2001. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J. Biol. Chem. 276: 16045–16050.
   PubMed Web of Science ®Google Scholar
• Cheng, P. 1996. Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum. Gene Ther. 7: 275–282.
   PubMed Web of Science ®Google Scholar
• Cunnick, J. M., J. F. Dorsey, T. Standley, J. Turkson, A. J. Kraker, D. W. Fry, R. Jove, and J. Wu. 1998. Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway. J. Biol. Chem. 273: 14468–14475.
   PubMedGoogle Scholar
• Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95–105.
   PubMed Web of Science ®Google Scholar
• Devary, Y., R. A. Gottlieb, T. Smeal, and M. Karin. 1992. The mammalian ultraviolet response is triggered by activation of src tyrosine kinases. Cell 71: 1081–1091.
   PubMed Web of Science ®Google Scholar
• Dong, J., L. K. Opresko, P. J. Dempsey, D. A. Lauffenburger, R. J. Coffey, and H. S. Wiley. 1999. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 96: 6235–6240.
   PubMed Web of Science ®Google Scholar
• Dong, J., and H. S. Wiley. 2000. Trafficking and proteolytic release of epidermal growth factor receptor ligands are modulated by their membrane-anchoring domains. J. Biol. Chem. 275: 557–564.
   PubMedGoogle Scholar
• Eguchi, S., P. J. Dempsey, G. D. Frank, E. D. Motley, and T. Inagami. 2001. Activation of MAP kinases by angiotensin II in vascular smooth muscle cells: metalloprotease-dependent EGF receptor activation is required for ERK and p38 MAP kinase, but not for JNK. J. Biol. Chem. 276: 7957–7962.
   PubMed Web of Science ®Google Scholar
• Eguchi, S., H. Iwasaki, Y. Hirata, J. D. Frank, E. D. Motley, T. Yamakawa, K. Numaguchi, and T. Inagami. 1999. Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II. Eur. J. Pharmacol. 376: 203–206.
   PubMedGoogle Scholar
• Eguchi, S., H. Iwasaki, T. Inagami, K. Numaguchi, T. Yamakawa, E. D. Motley, K. M. Owada, F. Marumo, and Y. Hirata. 1999. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33: 201–206.
   PubMedGoogle Scholar
• Eguchi, S., H. Iwasaki, E. D. Motley, G. D. Frank, H. Ueno, K. Eguchi, F. Marumo, Y. Hirata, and T. Inagami. 1999. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser411 in vascular smooth muscle cells: possible requirement of EGF receptor, RAS, ERK, and AKT. J. Biol. Chem. 274: 36843–36852.
   PubMedGoogle Scholar
• Eguchi, S., T. Matsumoto, E. D. Motley, H. Utsunomiya, and T. Inagami. 1996. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase. J. Biol. Chem. 271: 14169–14175.
   PubMed Web of Science ®Google Scholar
• Eguchi, S., K. Numaguchi, H. Iwasaki, T. Matsumoto, T. Yamakawa, H. Utsunomiya, E. D. Motley, H. Kawakatsu, K. M. Owada, Y. Hirata, F. Marumo, and T. Inagami. 1998. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273: 8890–8896.
   PubMed Web of Science ®Google Scholar
• Fan, H., and R. Derynck. 1999. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18: 6962–6972.
   PubMedGoogle Scholar
• Finkel, T. 1998. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10: 248–253.
   PubMed Web of Science ®Google Scholar
• Finkel, T., and N. J. Holbrook. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239–247.
   PubMed Web of Science ®Google Scholar
• Frank, G. D., S. Eguchi, T. Inagami, and E. D. Motley. 2001. N-acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. Biochem. Biophys. Res. Commun. 280: 1116–1119.
   PubMedGoogle Scholar
• Frank, G. D., S. Eguchi, E. D. Motley, T. Sasaki, and T. Inagami. 2001. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 286: 692–696.
   PubMedGoogle Scholar
• Frank, G. D., E. D. Motley, T. Inagami, and S. Eguchi. 2000. PYK2/CAKbeta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 270: 761–765.
   PubMed Web of Science ®Google Scholar
• Frank, G. D., S. Saito, E. D. Motley, T. Sasaki, M. Ohba, and T. Inagami. 2002. Requirement of Ca2+ and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2. Mol. Endocrinol. 16: 367–377.
   PubMed Web of Science ®Google Scholar
• Gechtman, Z., J. L. Alonso, G. Raab, D. E. Ingber, and M. Klagsbrun. 1999. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 274: 28828–28835.
   PubMedGoogle Scholar
• Govindarajan, G., D. M. Eble, P. A. Lucchesi, and A. M. Samarel. 2000. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells. Circ. Res. 87: 710–716.
   PubMedGoogle Scholar
• Griendling, K. K., D. Sorescu, and M. Ushio-Fukai. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86: 494–501.
   PubMed Web of Science ®Google Scholar
• Griendling, K. K., F. M. Ushio, B. Lassegue, and R. W. Alexander. 1997. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29: 366–373.
   PubMed Web of Science ®Google Scholar
• Gschwendt, M., H. J. Muller, K. Kielbassa, R. Zang, W. Kittstein, G. Rincke, and F. Marks. 1994. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199: 93–98.
   PubMed Web of Science ®Google Scholar
• Gschwind, A., E. Zwick, N. Prenzel, M. Leserer, and A. Ullrich. 2001. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20: 1594–1600.
   PubMed Web of Science ®Google Scholar
• Hansen, L. L., Y. Ikeda, G. S. Olsen, A. K. Busch, and L. Mosthaf. 1999. Insulin signaling is inhibited by micromolar concentrations of H2O2. J. Biol. Chem. 274: 25078–25084.
   PubMed Web of Science ®Google Scholar
• Heeneman, S., J. Haendeler, Y. Saito, M. Ishida, and B. C. Berk. 2000. Angiotensin II induces transactivation of the platelet-derived growth factor beta receptor. J. Biol. Chem. 275: 15926–15932.
   PubMed Web of Science ®Google Scholar
• Irani, K. 2000. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87: 179–183.
   PubMed Web of Science ®Google Scholar
• Ishino, M., H. Aoto, H. Sasaski, R. Suzuki, and T. Sasaki. 2000. Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn. FEBS Lett. 474: 179–183.
   PubMedGoogle Scholar
• Izumi, Y., M. Hirata, H. Hasuwa, R. Iwamoto, T. Umata, K. Miyado, Y. Tamai, T. Kurisaki, A. Sehara-Fujisawa, S. Ohno, and E. Mekada. 1998. A metalloprotease-disintegrin, MDC9/meltrin-g/ADAM9 and PKCd are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17: 7260–7272.
   PubMed Web of Science ®Google Scholar
• Kalmes, A., B. R. Vesti, G. Daum, J. A. Abraham, and A. W. Clowes. 2000. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ. Res. 87: 92–98.
   PubMed Web of Science ®Google Scholar
• Knebel, A., H. J. Rahmsdorf, A. Ullrich, and P. Herrlich. 1996. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. 15: 5314–5325.
   PubMed Web of Science ®Google Scholar
• Konishi, H., M. Tanaka, Y. Takemura, H. Matsuzaki, Y. Ono, U. Kikkawa, and Y. Nishizuka. 1997. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc. Natl. Acad. Sci. USA 94: 11233–11237.
   PubMed Web of Science ®Google Scholar
• Lander, H. M. 1997. An essential role for free radicals and derived species in signal transduction. FASEB J. 11: 118–124.
   PubMed Web of Science ®Google Scholar
• Lemjabbar, H., and C. Basbaum. 2002. Platelet-activating factor receptor and ADAM10 mediate responses to Staphylococcus aureus in epithelial cells. Nat. Med. 8: 41–46.
   PubMed Web of Science ®Google Scholar
• Lev, S., H. Moreno, R. Martinez, P. Canoll, E. Peles, J. M. Musacchio, G. D. Plowman, B. Rudy, and J. Schlessinger. 1995. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions. Nature 376: 737–745.
   PubMed Web of Science ®Google Scholar
• Levitzki, A., and A. Gazit. 1995. Tyrosine kinase inhibition: an approach to drug development. Science 267: 1782–1788.
   PubMed Web of Science ®Google Scholar
• Luttrell, L. M., Y. Daaka, and R. J. Lefkowitz. 1999. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11: 177–183.
   PubMed Web of Science ®Google Scholar
• Luttrell, L. M., R. G. Della, T. van Biesen, D. K. Luttrell, and R. J. Lefkowitz. 1997. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272: 4637–4644.
   PubMedGoogle Scholar
• Madamanchi, N. R., S. Li, C. Patterson, and M. S. Runge. 2001. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J. Biol. Chem. 276: 18915–18924.
   PubMed Web of Science ®Google Scholar
• Ohba, M., K. Ishino, M. Kashiwagi, S. Kawabe, K. Chida, N. Huh, and T. Kuroki. 1998. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the η and δ isoforms of protein kinase C. Mol. Cell. Biol. 18: 5199–5207.
   PubMed Web of Science ®Google Scholar
• Ohmori, S., Y. Shirai, N. Sakai, M. Fujii, H. Konishi, U. Kikkawa, and N. Saito. 1998. Three distinct mechanisms for translocation and activation of the delta subspecies of protein kinase C. Mol. Cell. Biol. 18: 5263–5271.
   PubMedGoogle Scholar
• Pai, R., B. Soreghan, I. L. Szabo, M. Pavelka, D. Baatar, and A. S. Tarnawski. 2002. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8: 289–293.
   PubMed Web of Science ®Google Scholar
• Pierce, K. L., A. Tohgo, S. Ahn, M. E. Field, L. M. Luttrell, and R. J. Lefkowitz. 2001. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J. Biol. Chem. 276: 23155–23160.
   PubMedGoogle Scholar
• Prenzel, N., E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich. 1999. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884–888.
   PubMed Web of Science ®Google Scholar
• Rao, G. N. 1996. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 13: 713–719.
   PubMed Web of Science ®Google Scholar
• Rocic, P., and P. A. Lucchesi. 2001. Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin II-induced signaling in vascular smooth muscle. J. Biol. Chem. 276: 21902–21906.
   PubMedGoogle Scholar
• Sasaki, H., K. Nagura, M. Ishino, H. Tobioka, K. Kotani, and T. Sasaki. 1995. Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J. Biol. Chem. 270: 21206–21219.
   PubMed Web of Science ®Google Scholar
• Schieffer, B., M. Luchtefeld, S. Braun, A. Hilfiker, D. Hilfiker-Kleiner, and H. Drexler. 2000. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ. Res. 87: 1195–1201.
   PubMed Web of Science ®Google Scholar
• Schindler, C., and J. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64: 621–651.
   PubMed Web of Science ®Google Scholar
• Shichiri, M., M. Yokokura, F. Marumo, and Y. Hirata. 2000. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler. Thromb. Vasc. Biol. 20: 989–997.
   PubMedGoogle Scholar
• Simon, A. R., U. Rai, B. L. Fanburg, and B. H. Cochran. 1998. Activation of the JAK-STAT pathway by reactive oxygen species. Am. J. Physiol. 275: C1640–C1652.
   PubMed Web of Science ®Google Scholar
• Soltoff, S. P. 2001. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J. Biol. Chem. 276: 37986–37992.
   PubMedGoogle Scholar
• Sun, X., W. Frank, R. Datta, S. Kharbanda, and D. Kufe. 2000. Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J. Biol. Chem. 275: 7470–7473.
   PubMedGoogle Scholar
• Suzuki, M., G. Raab, M. A. Moses, C. A. Fernandez, and M. Klagsbrun. 1997. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272: 31730–31737.
   PubMedGoogle Scholar
• Tokumaru, S., S. Higashiyama, T. Endo, T. Nakagawa, J. I. Miyagawa, K. Yamamori, Y. Hanakawa, H. Ohmoto, K. Yoshino, Y. Shirakata, Y. Matsuzawa, K. Hashimoto, and N. Taniguchi. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151: 209–220.
   PubMed Web of Science ®Google Scholar
• Touyz, R. M., and E. L. Schiffrin. 1999. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34: 976–982.
   PubMed Web of Science ®Google Scholar
• Umata, T., M. Hirata, T. Takahashi, F. Ryu, S. Shida, Y. Takahashi, M. Tsuneoka, Y. Miura, M. Masuda, Y. Horiguchi, and E. Mekada. 2001. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 276: 30475–30482.
   PubMedGoogle Scholar
• Ushio-Fukai, M., K. K. Griendling, P. L. Becker, L. Hilenski, S. Halleran, and R. W. Alexander. 2001. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21: 489–495.
   PubMed Web of Science ®Google Scholar
• Wang, D., X. Yu, R. A. Cohen, and P. Brecher. 2000. Distinct effects of N-acetylcysteine and nitric oxide on angiotensin II-induced epidermal growth factor receptor phosphorylation and intracellular Ca2+ levels. J. Biol. Chem. 275: 12223–12230.
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., H. Matsuzaki, H. Konishi, Y. Ono, and U. Kikkawa. 2000. H2O2-induced tyrosine phosphorylation of protein kinase cdelta by a mechanism independent of inhibition of protein-tyrosine phosphatase in CHO and COS-7 cells. Biochem. Biophys. Res. Commun. 273: 960–966.
   PubMedGoogle Scholar
• Yu, W. H., J. F. Woessner, Jr., J. D. McNeish, and I. Stamenkovic. 2002. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16: 307–323.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., P. Oliver, J. J. Lancaster, P. O. Schwarzenberger, M. S. Joshi, J. Cork, and J. K. Kolls. 2001. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15: 303–305.
   PubMedGoogle Scholar